Active Stocks
Mon Nov 10 2025 10:52:50
  1. Tata Steel share price
  2. 180.60 -0.47%
  1. Bharat Electronics share price
  2. 414.75 0.12%
  1. Infosys share price
  2. 1,513.95 2.48%
  1. Eternal share price
  2. 305.10 -0.28%
  1. Axis Bank share price
  2. 1,223.90 0.05%
Business News/Market/Market Stats/    Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

+
Invest
Explore On
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
30.92 -0.15 (-0.48%) NAV as on 07 Nov, 2025
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)829.63
  • CAGR -0.83%
  • Exit Load1.00%
  • Expense ratio2.32%
  • CategoryEquity
  • Min Investment1000
  • Min SIP100
  • Launch Date2019-07-11

Morning Star Rating N.A.

Medium
Risk
Exceptional
Return

Asset Allocation

Holdings As On - 10 November 2025

  • Name
  • Value (Cr)
  • Holding %
View More

Risk & Volitility

  • Alpha 0.00%
  • Beta 0.00
  • Sharpe Ratio0.85
  • Std Deviation 16.02%
  • Tracking Error 0.00%

About Fund

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

 

The Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has an AUM of 829.63 crores & has delivered CAGR of 15.72% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.32%. The minimum investment in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is Rs 1000 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Apollo Hospitals Enterprise, Cipla & Fortis Healthcare.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Investment Services.

 

Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Tata India Pharma & Healthcare Fund Regular Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth. Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.85 & a standard deviation of 16.02%.

Mutual Fund News

Inside Nippon’s plan to win over India’s new-age investors

5 min read . 09 Nov 2025

Sebi eases pro-rata rule for AIFs, offers clarity on investor commitments

3 min read . 07 Nov 2025

These top-performing value funds delivered over 20% CAGR in the past 3 years

2 min read . 07 Nov 2025

Sebi to form working group to revamp short-selling, securities-lending rules

2 min read . 07 Nov 2025
View More News

FAQs about Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

According to the morning star rating Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is managed by Dhaval Shah.
The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is 2.32%.
The 5 year annualized return on Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is 15.72% & it has generated -0.83% in the last 1 year.
The minimum investment in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is 1000 Rs.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has an AUM of 829.63 crores.
Recommended For You